←
Jamie S. Y. Ho787 posts
Jamie S. Y. Ho avatar

Jamie S. Y. Ho

@JamieSYHo

Cardiology Registrar and NIHR Academic Clinical Fellow, Cambridge 👩🏻‍⚕️ | MBBChir @Cambridge_Uni | Interests: heart, brain @strocarcollab

◷ Joined May 2010▧ 95 Photos and videos
Jamie S. Y. Ho avatar
Jamie S. Y. Ho@JamieSYHo·Nov 14

Learning so much from Prof Greg Lip in the How to Write a Paper Workshop, from the perspective of the editor ✍️ > don’t do bad science > read the instructions to authors and the scope of the journal > convince the editor of the research novelty in the cover letter > write a good abstract that captures the editor’s attention - clear hypothesis/objective and highlight key findings and conclusions #HSET2026 #ESCHeartandStroke @ESCStrokeChair @JacopoImberti

Post attachment
Jamie S. Y. Ho avatar
Jamie S. Y. Ho@JamieSYHo·Nov 14

An intensely informative debate: should we stop anticoagulation after ablation & rhythm control in AF? 🫀 Current CoS chair Prof Renate Schnabel (YES) vs past-chair Prof Gregory Lip (NO) 🩸 OCEAN & ALONE-AF support discontinuation in pts with low stroke risk, high bleeding risk & no recurrence for ≥1 yr ⚠️ But risk is dynamic, and the burden of monitoring recurrence & new comorbidities falls on clinician and patient ⚠️ Trials may be underpowered to detect stroke, few events were reported Open questions:
🔍 How much monitoring of AF recurrence is enough? For how long?
📟 ILR vs prolonged Holter? But what is the AF burden that is clinically relevant?
🧠 Beyond stroke: heart failure & cognitive outcomes (e.g. dementia) matter too ⭐️ A comprehensive view of the patient regarding the co-morbidities other etiologies of stroke is essential #HSET2026 #ESCHeartandStroke @ESCStrokeChair @RenateSchn614 @WoDoehner @JacopoImberti

Post attachmentPost attachmentPost attachment
Jamie S. Y. Ho avatar
Jamie S. Y. Ho@JamieSYHo·Nov 14

What an honor to present this Council of Stroke survey on patent foramen ovale practices internationally in the Hotline 1 session🤩 ➡️366 clinicians from 95 countries surveyed ➡️routine PFO screening after ESUS is common but selection of tests to screen varies (most commonly TTE/TEE with contrast) ➡️PFO closure in older patients >60 years is considered by most, depending on RoPE/PASCAL and PFO features ➡️mixed thoughts on PFO closure in pts with thrombophilia (excluded from RCTs) ➡️most common medical therapy post PFO closure is DAPT for 3 months or more then SAPT ➡️heart brain team is only available to 1/3 despite guideline recommendations @DrBenjaminTan #HSET2026

Post attachment
Jamie S. Y. Ho avatar
Jamie S. Y. Ho@JamieSYHo·Nov 13

🚨Keynote lecture HSET 2026 State of the art in stroke prevention & integrated care in atrial fibrillation by Prof Greg Lip 
• The ABC pathway for integrated care, with the patient at the centre
• Risk in AF is dynamic, and so is rhythm. Consider AF density, burden and progression • AF is heterogeneous and clinically complex. Most deaths in AF patients come from cardiovascular disease, not only stroke, so managing CV risk factors is essential
• Early rhythm control and ablation, plus a healthy lifestyle, have additive effects on reducing stroke • Stopping anticoagulants after ablation in patients with a CHA₂DS₂-VASc score of 2 or more is associated with more strokes
• Environment matters too: exposures like ozone can raise the risk of AF and adverse outcomes Managing AF is as easy as “ABC” 🫀 
#HSET2026 @ESCStrokeChair @ESCWGThrombosis @JacopoImberti @escardio

Post attachment
Jacopo Imberti avatar
⟳ Jamie S. Y. Ho retweeted
Jacopo Imberti@JacopoImberti·Nov 13

🎙️ Keynote Lecture by Prof. Lina Badimon: The pathophysiology of arterial thrombosis: the past, the present and the future. A journey from Virchow’s triad ➡️ integrative vascular biology ➡️ novel drug development. @ESCStrokeChair @escardio @JamieSYHo

Post attachmentPost attachment
Jamie S. Y. Ho avatar
Jamie S. Y. Ho@JamieSYHo·Nov 13

🚨Keynote Lecture📖 Prof Lina Badimon explored the mechanisms + pathways behind arterial thrombosis and the evolution of antithrombotic therapy Focused on platelets, inflammation and fibrinolysis, which may have implications on developing new therapies for CV disease, aging and cognition Chaired by Diana Gorog, Bruna Gigante Particularly topical given the recent FDA approval for Factor XIa inhibitors for stroke! 🩸 @ESCStrokeChair @ESCWGThrombosis @JacopoImberti @manea_mirabela @Fra_Vitali90

Post attachmentPost attachmentPost attachmentPost attachment
Jamie S. Y. Ho avatar
Jamie S. Y. Ho@JamieSYHo·Nov 13

This year there is a new 3rd track for basic and translational science, and the new mentorship corner + workshops. Hope to make some new connections and have fruitful discussions 🤓